Semaglutide in Dallas, Little Elm/Frisco, TX
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that is available as a solution and oral form. Semaglutide has been approved as a treatment option for the management of type 2 diabetes and is currently used as weight management therapy in people who are obese or overweight.
Semaglutide is proven to be safe for adults and elderly patients with renal or hepatic disorders. Results from cardiovascular trials have also proven that wegovy can reduce various cardiovascular risk factors.
Semaglutide activates the GLP-1 receptors, which improves the efficiency of incretin function. It works in different ways, such as augmented insulin secretion, inhibition of glucagon release, and suppressed hepatic gluconeogenesis, which suppresses hunger. It also improves insulin sensitivity, which is likely to result in an overall reduction in body weight. It causes weight loss via reduced energy intake and a delay in gastric motility.
